Company / Operating Cash Flow per Share
Supernus Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.85
FY2025
5-year range
$0.85 / $3.14
FY2021-FY2025
Trend
-73.0%
vs FY2024
Sector context
#58 of 212
Health Care
What the data says
At $0.85, Supernus Pharmaceuticals, Inc.'s operating cash flow per share ranks #58 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.50 in FY2016 to $3.14 in FY2024.
Based on SEC 10-K filings.
0.85 in FY2025 with a 5-year CAGR of -20.3%.
Declined from $2.00 to $0.85 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -27.1%
- 5-Year CAGR
- -20.3%
- 10-Year CAGR
- -
Sector benchmark
+105.8% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 73.0% year-over-year.
- Ranks #58 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.85 | -73.0% |
| FY2024 | $3.14 | +57.0% |
| FY2023 | $2.00 | -8.8% |
| FY2022 | $2.19 | -8.8% |
| FY2021 | $2.40 | -8.7% |
| FY2020 | $2.63 | -3.7% |
| FY2019 | $2.74 | +110.1% |
| FY2018 | $1.30 | +88.5% |
| FY2017 | $0.69 | +238.2% |
| FY2016 | -$0.50 | -162.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026